Alecia Greenlee, MD
Psychosomatic Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Greenlee’s office at (408) 800-5363 to ask if they take your plan before you enroll.
California Medical Board record
Licence A169680 · Current
Licensed to practise in California · since 2020 · expires 2028-08-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$74,795 in 2024
Medicaid paid $74,795 for 1,026 billed services this clinician did in 2024, up to 36 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 323 | $67,102 |
| Short return visit (20+ min) | 118 | $4,101 |
| Return visit (30+ min) | 59 | $3,592 |
| TOBACCO NON-USER | 64 | $0 |
| Medication list documented in medical record (COA) | 231 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 231 | $0 |
| 2024 | 1,026 | 6 | 36 | $74,795 |
| 2023 | 897 | 8 | 42 | $63,252 |
| 2022 | 824 | 7 | 42 | $56,957 |
| 2020 | 657 | 3 | 37 | $60,196 |
| 2019 | 431 | 2 | 30 | $39,757 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 280 | $58,361 |
| Short return visit (20+ min) | 164 | $3,927 |
| Return visit (30+ min) | 53 | $705 |
| Psychiatric diagnostic evaluation with medical services | 16 | $258 |
| Medication list documented in medical record (COA) | 37 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 37 | $0 |
| Telehealth originating site facility fee | 155 | $0 |
| Telehealth transmission, per minute, professional services bill separately | 155 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 291 | $56,804 |
| Psychiatric diagnostic evaluation with medical services | 30 | $86 |
| Return visit (30+ min) | 32 | $67 |
| Short return visit (20+ min) | 36 | $0 |
| Annual alcohol misuse screening, 5 to 15 minutes | 33 | $0 |
| Telehealth originating site facility fee | 207 | $0 |
| Telehealth transmission, per minute, professional services bill separately | 195 | $0 |
2020
| Return visit (30+ min) | 235 | $23,469 |
| Short return visit (20+ min) | 320 | $20,831 |
| Psychiatric diagnostic evaluation with medical services | 102 | $15,896 |
2019
| Psychiatric diagnostic evaluation with medical services | 153 | $24,588 |
| Short return visit (20+ min) | 278 | $15,168 |
Drugs they prescribed that Part D paid
$9,421
Pharmacies billed $9,421 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 80) in 2024. At or below the middle of the specialty; the typical neuropsychiatry clinician is at 0%.
80 generic and 0 brand-name prescriptions · $9,421 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diazepam | 12 | $54 | $4 |
Year by year
| 2024 | 80 | None | 0% (0) | 0% | $9,421 |
| 2023 | 138 | 11 | 0% (0) | None | $43,108 |
| 2022 | 171 | 17 | 0% (0) | 9% | $43,252 |
| 2021 | 70 | 16 | 0% (0) | None | $1,454 |
| 2020 | 1,150 | 72 | 0% (0) | 10% | $211,278 |
| 2019 | 526 | 51 | 0% (0) | 11% | $101,376 |
| 2017 | 38 | None | 0% (0) | 0% | $417 |
| 2016 | 59 | 16 | 0% (0) | None | $4,681 |
| 2015 | 42 | 12 | 0% (0) | None | $1,364 |
| 2014 | 21 | 13 | 0% (0) | None | $1,076 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Lurasidone | 15 | $14,727 | $982 |
| Olanzapine | 17 | $1,708 | $100 |
| Hydroxyzine Pamoate | 11 | $781 | $71 |
2022: 5 drugs
| Latuda | 15 | $32,177 | $2,145 |
| Quetiapine | 14 | $2,645 | $189 |
| Divalproex Sodium Er | 13 | $2,434 | $187 |
| Guanfacine Hcl Er | 12 | $1,056 | $88 |
| Gabapentin | 12 | $543 | $45 |
2020: 32 drugs
| Invega Sustenna | 31 | $53,696 | $1,732 |
| Latuda | 37 | $49,318 | $1,333 |
| Aripiprazole | 22 | $4,103 | $186 |
| Ziprasidone | 29 | $3,727 | $129 |
| Quetiapine | 140 | $3,330 | $24 |
| Divalproex Sodium Er | 21 | $2,869 | $137 |
| Duloxetine | 30 | $2,503 | $83 |
| Clozapine | 26 | $2,393 | $92 |
| Haloperidol Decanoate | 22 | $2,164 | $98 |
| Dexmethylphenidate Hcl Er | 13 | $1,926 | $148 |
| Olanzapine | 58 | $1,837 | $32 |
| Gabapentin | 47 | $1,257 | $27 |
| Mirtazapine | 43 | $1,193 | $28 |
| Dextroamphetamine-Amphet Er | 16 | $1,013 | $63 |
| Buspirone | 11 | $992 | $90 |
| Venlafaxine Hcl Er | 42 | $801 | $19 |
| Bupropion Xl | 30 | $797 | $27 |
| Hydroxyzine | 30 | $796 | $27 |
| Trazodone | 60 | $784 | $13 |
| Benztropine Mesylate | 41 | $530 | $13 |
| Sertraline | 31 | $512 | $17 |
| Oxcarbazepine | 11 | $478 | $43 |
| Escitalopram | 39 | $448 | $11 |
| Alprazolam | 29 | $397 | $14 |
| Prazosin | 19 | $392 | $21 |
| Lorazepam | 33 | $390 | $12 |
| Risperidone | 36 | $387 | $11 |
| Clonazepam | 62 | $304 | $5 |
| Lamotrigine | 17 | $261 | $15 |
| Propranolol | 16 | $203 | $13 |
| Dextroamphetamine-Amphetamine | 11 | $167 | $15 |
| Citalopram Hbr | 12 | $89 | $7 |
2019: 19 drugs
| Invega Sustenna | 13 | $18,969 | $1,459 |
| Aripiprazole | 15 | $3,866 | $258 |
| Divalproex Sodium Er | 19 | $2,391 | $126 |
| Quetiapine | 61 | $2,237 | $37 |
| Duloxetine | 26 | $2,176 | $84 |
| Ziprasidone | 15 | $1,915 | $128 |
| Haloperidol Decanoate | 13 | $1,342 | $103 |
| Clozapine | 12 | $935 | $78 |
| Olanzapine | 39 | $794 | $20 |
| Trazodone | 23 | $382 | $17 |
| Benztropine Mesylate | 18 | $279 | $15 |
| Risperidone | 19 | $247 | $13 |
| Bupropion Xl | 12 | $212 | $18 |
| Clonazepam | 24 | $212 | $9 |
| Hydroxyzine | 11 | $203 | $18 |
| Sertraline | 12 | $167 | $14 |
| Escitalopram | 15 | $156 | $10 |
| Lorazepam | 11 | $135 | $12 |
| Alprazolam | 11 | $79 | $7 |
2017: 1 drug
| Lorazepam | 12 | $38 | $3 |
Professional record
- NPI
- 1487072922
- Licence
- CA A169680, IL 336.107121, MA 269603California A169680: Current · expires 2028-08-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084P0015X (2084P0015X); Psychiatry (2084P0800X)
- Mailing address
- 500 E Hamilton Ave # 1020, Campbell, CA, 95008
- NPI first listed
- 2014-04-02
- NPI last updated
- 2026-03-10
- NPI record certified
- 2026-03-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3107 Fillmore St, San Francisco, CA, 94123